HIV News and Research

RSS

Study proposes new approach that cures multidrug-resistant TB in conflict-affected communities

A high proportion of multidrug-resistant tuberculosis cases can be cured in conflict-affected communities with molecular diagnostics, shorter treatment periods and socioeconomic incentives, according to the results of a large, long-term study in the Democratic Republic of Congo led by the University of Pittsburgh Graduate School of Public Health and Stellenbosch University in South Africa, in collaboration with the DRC National Tuberculosis Program.

14 Feb 2019

Relapse dreams more common in people with severe alcohol, drug addiction history

Vivid dreams involving drinking and drug use are common among individuals in recovery. A study from the Massachusetts General Hospital Recovery Research Institute, published in the January issue of the Journal of Substance Abuse Treatment after online release in October 2018, finds these relapse dreams are more common in those with more severe clinical histories of alcohol and other drug problems.

13 Feb 2019

New bioengineered device enhances the production of T-cells

Bone marrow transplants, also known as hematopoietic stem cell transplants, are life-saving treatments for aggressive diseases, such as leukemia and multiple myeloma, and infections such as HIV. The procedure entails infusion of blood stem cells from a matched donor into the patient to 'reset' the blood and immune system.

12 Feb 2019

MGH researchers identify brain cells that modulate behavioral response to threats

A team of investigators from the Massachusetts General Hospital (MGH) Center for Regenerative Medicine has identified a population of brain cells that appears to play a role in calibrating behavioral responses to potentially threatening situations.

12 Feb 2019

Research reveals critical immunological axis that triggers cancer-promoting chronic inflammation

A Massachusetts General Hospital research team has identified interaction between two elements of the immune system as critical for the transformation of a protective immune response into chronic, cancer-promoting inflammation.

12 Feb 2019

New measurable indicator could prove instrumental in fight against HIV

George Mason University's Yuntao Wu is the lead scientist on a research team that has identified a measurable indicator that could prove instrumental in the fight against HIV.

11 Feb 2019

IAS 2019 plenary program spotlights urgent developments in HIV science

The International AIDS Society has announced the plenary presentations that will lead the 10th IAS Conference on HIV Science, which will take place in Mexico City, Mexico, on 21-24 July 2019. IAS 2019 is the largest open scientific conference on HIV and is expected to bring together more than 6,000 participants from more than 140 countries.

8 Feb 2019

New clinical trial aims to examine safety and use of two HIV prevention tools

A clinical trial has begun to examine the safety and use of two HIV prevention tools--oral pre-exposure prophylaxis and a vaginal ring--in adolescent girls and young women in southern Africa.

8 Feb 2019

Increase in vocal-cord cancers among young adults appears to be the result of HPV infection

A remarkable recent increase in the diagnosis of vocal-cord cancer in young adults appears to be the result of infection with strains of human papilloma virus that also cause cervical cancer and other malignancies.

8 Feb 2019

MTN launches new study to empower teen girls with choices in HIV prevention

AIDS is already the leading cause of death among girls and young women in much of Africa, and matters could only get worse, given that for every day that passes, 1,000 more girls ages 15 to 24 are likely to become infected with HIV.

8 Feb 2019

Researchers develop intervention to encourage couples HIV testing

It's long been known that couples HIV testing and counseling is an effective way to mutually disclose HIV status and link to health care--unfortunately, couples don't use it even though it's widely available.

8 Feb 2019

Podcast: KHN’s ‘What the Health?’ A ‘healthy’ state of the union

Health policy played a surprisingly robust role in President Donald Trump's 2019 State of the Union address.

7 Feb 2019

Trump administration salutes parade of generic drug approvals, but hundreds aren’t for sale

The Trump administration has been trumpeting a huge increase in FDA generic drug approvals the past two years, the result of its actions to streamline a cumbersome process and combat anti-competitive practices.

7 Feb 2019

UNC-led scientists receive $5.1 million grant to combat cervical cancer in Malawi

Backed by a $5.1 million grant, University of North Carolina and University of Malawi College of Medicine physicians and scientists will launch a multi-pronged effort to combat cervical cancer in Malawi, a country in sub-Saharan Africa where cervical cancer is the leading cause of cancer death among women.

7 Feb 2019

First therapy indicated for treating adults with rare blood clotting disorder receives FDA approval

The U.S. Food and Drug Administration today approved Cablivi (caplacizumab-yhdp) injection, the first therapy specifically indicated, in combination with plasma exchange and immunosuppressive therapy, for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), a rare and life-threatening disorder that causes blood clotting.

7 Feb 2019

Trump pledges to end HIV transmission by 2030. Doable, but daunting.

Noting that science has "brought a once-distant dream within reach," President Donald Trump on Tuesday night pledged to eliminate HIV transmission within 10 years.

6 Feb 2019

Trump highlights health agenda with vow to lower ‘unfair’ drug prices

It was not the centerpiece, but health was a persistent theme in President Donald Trump's State of the Union address at the Capitol on Tuesday night.

6 Feb 2019

HIV-1 protein plays broader role in suppressing immune response than thought

Scientists have revealed how a protein produced by HIV-1 plays a broader role in suppressing the immune system's response to infection than previously thought.

6 Feb 2019

Researchers harness immune system to reveal new clues to produce HIV vaccine

The immune system is the body's best defense in fighting diseases like HIV and cancer. Now, an international team of researchers is harnessing the immune system to reveal new clues that may help in efforts to produce an HIV vaccine.

4 Feb 2019

Opioid overdose epidemic likely to increase in the U.S in coming years

A study from investigators at the Massachusetts General Hospital Institute for Technology Assessment projects that the opioid overdose epidemic in the U.S. is likely to increase in coming years, and that measures based on restricting access to prescription opioids will have a minimal impact in reducing overdose deaths.

3 Feb 2019

HIV News and Research

Study proposes new approach that cures multidrug-resistant TB in conflict-affected communities

Relapse dreams more common in people with severe alcohol, drug addiction history

New bioengineered device enhances the production of T-cells

MGH researchers identify brain cells that modulate behavioral response to threats

Research reveals critical immunological axis that triggers cancer-promoting chronic inflammation

New measurable indicator could prove instrumental in fight against HIV

IAS 2019 plenary program spotlights urgent developments in HIV science

New clinical trial aims to examine safety and use of two HIV prevention tools

Increase in vocal-cord cancers among young adults appears to be the result of HPV infection

MTN launches new study to empower teen girls with choices in HIV prevention

Researchers develop intervention to encourage couples HIV testing

Podcast: KHN’s ‘What the Health?’ A ‘healthy’ state of the union

Trump administration salutes parade of generic drug approvals, but hundreds aren’t for sale

UNC-led scientists receive $5.1 million grant to combat cervical cancer in Malawi

First therapy indicated for treating adults with rare blood clotting disorder receives FDA approval

Trump pledges to end HIV transmission by 2030. Doable, but daunting.

Trump highlights health agenda with vow to lower ‘unfair’ drug prices

HIV-1 protein plays broader role in suppressing immune response than thought

Researchers harness immune system to reveal new clues to produce HIV vaccine

Opioid overdose epidemic likely to increase in the U.S in coming years

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News